| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/28/2004 | CN1492040A Natural antibody of monoclonal human |
| 04/28/2004 | CN1491961A Amaranth seed ribosome inactivating protein |
| 04/28/2004 | CN1491942A Non humidity suction stable crystalline form of N-[N-N-(4-piperidine-4-yl)-N-ethyl glycyl) compound |
| 04/28/2004 | CN1491722A Compound alliin powder injection |
| 04/28/2004 | CN1491721A Oral prepn form of human interleukin 11 liposome |
| 04/28/2004 | CN1491720A Inducer of blood vessel neogenesis |
| 04/28/2004 | CN1491624A Modified biological material |
| 04/28/2004 | CN1147586C Nucleotide sequences of HIV-10 type (or subtype) retrovirus antigens |
| 04/28/2004 | CN1147584C Modulators of tissue regeneration |
| 04/28/2004 | CN1147505C G-protein receptor HTNAD 29 |
| 04/28/2004 | CN1147504C New thrombin inhibitors, their preparation and use |
| 04/28/2004 | CN1147317C Combination of tyrosine kinase inhibitor and chemical castration and its use in pharmaceutical production |
| 04/28/2004 | CN1147305C Extracts of shark cartilage having anti-angiogenic activity and effect on tumor regression, process of making thereof |
| 04/28/2004 | CA2447199A1 Homing of embryonic stem cells to a target zone in tissue using active therapeutics or substances |
| 04/28/2004 | CA2447190A1 Homing of donor cells to a target zone in tissue using active therapeutics or substances |
| 04/28/2004 | CA2447167A1 Homing of autologous cells to a target zone in tissue using active therapeutics or substances |
| 04/27/2004 | US6727366 Imidazolidinones and their related derivatives as hepatitis C virus NS3 protease inhibitors |
| 04/27/2004 | US6727355 Pharmaceutical composition for treatment of Duchenne muscular dystrophy |
| 04/27/2004 | US6727353 Nucleic acid encoding Kv10.1, a voltage-gated potassium channel from human brain |
| 04/27/2004 | US6727350 Toso |
| 04/27/2004 | US6727347 Method for preparing polycation based bioconjugates suitable for transporting different kinds of active substances within the body |
| 04/27/2004 | US6727346 Obtaining insulin precursors; generate suspension of insulin and cysteine hydrochloride, heat, recover insulin precursors |
| 04/27/2004 | US6727282 Human immunodeficiency virus (hiv) or aids treatment |
| 04/27/2004 | US6727252 Methods of modulating serine/threonine protein kinase function with 5-azaquinoxaline-based compounds |
| 04/27/2004 | US6727239 Inhibitory activity on no- synthase enzymes producing nitrogen monoxide no and/or an activity which traps the reactive oxygen species (ros) |
| 04/27/2004 | US6727232 Nucleoside peptide antibiotics of AA-896 |
| 04/27/2004 | US6727230 Anti-infective agent, anti- cancer agent, in conjunction with the surgery |
| 04/27/2004 | US6727227 Cause an increase in superoxide dismutase activity in said subject |
| 04/27/2004 | US6727226 Conotoxin peptide extracted from the venom of a marine snail, conus magnus (cono=cone); disorders associated with voltage gated sodium ion channel; neuromuscular blocking agents; local anesthetics; neuroprotective agents; analgesics |
| 04/27/2004 | US6727225 TWEAK receptor |
| 04/27/2004 | US6727224 Methods and compositions for healing and repair of articular cartilage |
| 04/27/2004 | US6727223 Biosurfactants for blocking the interaction of a pathogen with a collagen receptor |
| 04/27/2004 | US6727093 Peptides and immunologically functional variants thereof which are immunogenic epitopes recognized by cd8+ class i major histocompatibility complex restricted cytotoxic t-lymphocytes of patients harboring latent human cytomegalovirus infection |
| 04/27/2004 | US6727082 For identifying drugs that inhibit fungal gtpase activity, particularly those involved in cell wall integrity, hyphael formation and other functions critical to pathogenesis; isolated geranylgeranyl protein transferase |
| 04/27/2004 | US6727064 Antiinflammatory agents; anticarcinogenic agents |
| 04/27/2004 | US6727058 Transfecting cell with first polynucleotide comprising retroviral genome operably linked to first inducible transcription regulation element wherein retroviral genome is defective for self-replication, second, third polynucleotides |
| 04/27/2004 | US6726910 Immuno-reactive peptide CTL epitopes of human cytomegalovirus |
| 04/27/2004 | US6726909 Administering antibody |
| 04/27/2004 | US6726907 Purified adenoviral compositions |
| 04/27/2004 | US6726898 Inserting furanone derivative into pocket |
| 04/27/2004 | US6726895 Tumor radiotherapy |
| 04/27/2004 | US6726860 Production scale method of forming microparticles |
| 04/27/2004 | CA2295999C Nik proteins, nucleic acids and methods |
| 04/27/2004 | CA2187849C Uck14 compounds |
| 04/27/2004 | CA2187394C Diabetic nutritional product having controlled absorption of carbohydrate |
| 04/27/2004 | CA2096888C Process for the inactivation of viruses in preparations of proteins |
| 04/27/2004 | CA2058370C Monoclonal antibodies against human tumor necrosis factor .alpha. |
| 04/25/2004 | CA2446662A1 Plasmodium falciparum virulence factor var o |
| 04/25/2004 | CA2409897A1 Plasmodium falciparum virulence factor var o |
| 04/23/2004 | CA2444983A1 Oxidizing oil-in-water cream emulsion for the treatment of human keratin fibres |
| 04/22/2004 | WO2004034093A2 Caterpiller gene family |
| 04/22/2004 | WO2004034061A2 Method for determining the susceptibility of a subject to infection |
| 04/22/2004 | WO2004033723A2 Neurodegenerative disease-associated gene |
| 04/22/2004 | WO2004033717A1 Autism gene |
| 04/22/2004 | WO2004033691A2 Human lipid phosphate phosphatases and uses thereof for treating neuronal diseases |
| 04/22/2004 | WO2004033688A1 Cap-binding protein |
| 04/22/2004 | WO2004033687A1 Method of screening remedy for renal failure |
| 04/22/2004 | WO2004033686A1 Novel protein and dna thereof |
| 04/22/2004 | WO2004033681A1 Substance having activity of promoting platelet aggregation |
| 04/22/2004 | WO2004033678A1 Splice-variant of human pde6c |
| 04/22/2004 | WO2004033677A2 Secreted acid phosphatase (sapm) is present only in pathogenic mycobacteria and expressed selectively at acidic ph |
| 04/22/2004 | WO2004033675A1 Flavin protein of trypanosoma cruzi, method of screening vermicide with the use of the same and diagnostic |
| 04/22/2004 | WO2004033672A2 Stem cell expansion factor blocking a gene limiting hox-induced expansion and method using such factor |
| 04/22/2004 | WO2004033666A2 Method and compounds for inhibiting hec1 activity for the treatment of proliferative diseases |
| 04/22/2004 | WO2004033663A2 Carbohydrate-based synthetic vaccines for hiv |
| 04/22/2004 | WO2004033657A2 Heat shock protein binding fragments of cd91, and uses thereof |
| 04/22/2004 | WO2004033648A2 Isolated mammalian membrane protein genes; related reagents |
| 04/22/2004 | WO2004033645A2 Methods of regulating body weight |
| 04/22/2004 | WO2004033643A2 Methods of use of a dna helicase in the diagnosis and treatment of colon and lung cancer |
| 04/22/2004 | WO2004033642A2 Alpha 2hs glycoprotein for treatment of cancer and a method for preparation thereof |
| 04/22/2004 | WO2004033637A2 Extracellular messengers |
| 04/22/2004 | WO2004033634A2 Transgenic cells transfected with pituitary tumor transforming gene (pttg) expression vectors and uses therefor |
| 04/22/2004 | WO2004033631A2 Nucleic acid and polypeptide sequences from lawsonia intracellularis and methods of using |
| 04/22/2004 | WO2004033495A2 Regulation of human pde6b |
| 04/22/2004 | WO2004033490A2 Hcmv derived immunomodulatory polypeptide |
| 04/22/2004 | WO2004033489A1 Template-fixed peptidomimetics with antimicrobial activity |
| 04/22/2004 | WO2004033486A2 Production of homotrimeric fusion proteins |
| 04/22/2004 | WO2004033484A2 Use of stable glutamine derivatives to improve drug absorption |
| 04/22/2004 | WO2004033482A2 Phenolic binding peptides |
| 04/22/2004 | WO2004033481A2 Igf-binding protein-derived peptide or small molecule |
| 04/22/2004 | WO2004033479A2 Retroyclins: antiviral and antimicrobial peptides |
| 04/22/2004 | WO2004032955A1 Inhibitors for continuous activation of calcineurin |
| 04/22/2004 | WO2004032954A1 Method of treating chronic pelvic pain syndrome by administration of chrorionic gonadotropin |
| 04/22/2004 | WO2004032953A1 Treatment of allergic conditions by use of il 21 |
| 04/22/2004 | WO2004032952A1 Use of ghrelin for treating malnutrition in gastrectomized individuals |
| 04/22/2004 | WO2004032880A2 Method for inhibiting angiogenesis with ship-1 inhibitors |
| 04/22/2004 | WO2004032878A2 Compositions, organisms and methodologies employing a novel human kinase |
| 04/22/2004 | WO2004032867A2 Molecules preferentially associated with effector t cells or regulatory t cells and methods of their use |
| 04/22/2004 | WO2004032863A2 Oral formulations for proteins and polypeptides |
| 04/22/2004 | WO2004032855A2 Method for inhibiting angiogenesis with transforming growth factor-beta 3 inhibitors |
| 04/22/2004 | WO2004032851A2 Screening and therapeutic methods relating to neurogenesis |
| 04/22/2004 | WO2004032850A2 Uses of human zven antagonists |
| 04/22/2004 | WO2004032849A2 Methods of administering fgf18 |
| 04/22/2004 | WO2004032847A2 Hepatocyte growth factor variants |
| 04/22/2004 | WO2004032839A2 Methods and formulations comprising agonists and antagonists of nuclear hormone receptors |
| 04/22/2004 | WO2004032837A2 The use of cytokine able to bind il-18bp and of inhibiting the activity of a second cytokine |
| 04/22/2004 | WO2004032827A2 Hepatitis c virus inhibitors |
| 04/22/2004 | WO2004032825A2 Use of 2,3 alkylcarbonyloxybenzoic acids in the treatment of anthrax |
| 04/22/2004 | WO2004032789A2 Liposomal hgh composition and method for administration thereof |
| 04/22/2004 | WO2004032718A2 Cytokine antagonists for neurological and neuropsychiatric disorders |